GTX Signs Collaboration Agreement with Flint Rehab
February 06, 2019 08:35 ET
|
GTX Corp
LOS ANGELES, CALIFORNIA, Feb. 06, 2019 (GLOBE NEWSWIRE) -- GTX Corp (OTCQB: GTXO) (“GTX” or the “Company”), a pioneer in the field of wearable GPS, human and asset tracking systems and wandering...
3Scan Selected for Crucial efforts in NIH SPARC Initiative
December 07, 2018 10:04 ET
|
3Scan
San Francisco, Dec. 07, 2018 (GLOBE NEWSWIRE) -- 3Scan, Inc. (3Scan), the world’s leading 3D tissue imaging company has been contracted to provide crucial data in a multi-scale, multi-disciplinary...
National Cancer Institute Designates BrainHQ as a Research-Tested Intervention Program
November 05, 2018 08:00 ET
|
Posit Science
SAN FRANCISCO, Nov. 05, 2018 (GLOBE NEWSWIRE) -- The National Cancer Institute (NCI) of the US National Institutes of Health has designated BrainHQ online brain exercises, made by Posit Science, as...
Organization announces Early Career Research Award in the field of celiac disease
October 18, 2018 15:47 ET
|
Beyond Celiac
Philadelphia, PA, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Beyond Celiac is announcing the creation of the Society for the Study of Celiac Disease - Beyond Celiac Early Career Research Award, a joint...
Cellular Biomedicine Group Obtained NCI Patent License for Next Generation Neoantigen-Reactive Tumor Infiltrating Lymphocyte (TIL) Technology to Treat Solid Tumors
October 03, 2018 07:30 ET
|
Cellular Biomedicine Group Inc.
SHANGHAI, China and CUPERTINO, Calif., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in...
BioCorRx Provides BICX102 Grant Update
October 02, 2018 07:51 ET
|
BioCorRx Inc
ANAHEIM, CA, Oct. 02, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use...
Kannalife Sciences Finalizes Share Exchange Agreement with TYG Solutions Corp.
August 01, 2018 08:00 ET
|
Kannalife Sciences, Inc.
NEW YORK, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Kannalife Sciences, Inc. (“Kannalife”), a bio-pharmaceutical and phyto-medical company, is pleased to announce the completion of a share exchange...
BioNews Services Puts Sharp Focus on Rare Disease Day 2018
February 28, 2018 08:45 ET
|
BioNews Services
DALLAS, Feb. 28, 2018 (GLOBE NEWSWIRE) -- BioNews Services, the leading online health, science and research publisher serving patients with rare diseases, is using its editorial resources this month...
AFA: Signing of New RAISE Family Caregiver Law Positive Step, But Continued Action Needed from Washington
January 23, 2018 09:50 ET
|
Alzheimer's Foundation of America
NEW YORK, Jan. 23, 2018 (GLOBE NEWSWIRE) -- The Alzheimer’s Foundation of America (AFA) heralded the signing of the new RAISE Family Caregiver Act, which will provide a desperately needed...
CURE Pharmaceutical Subsidiary, Oak Therapeutics, Completes Critical Milestone in Phase 1 of NIH Grant to Develop Oral Dissolvable Strip for Tuberculosis
August 22, 2017 11:19 ET
|
CURE Pharmaceutical
OXNARD, Calif., Aug. 22, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology company, today announced that its subsidiary company, Oak...